Is repeat prostate biopsy associated with a greater risk of hospitalization? Data from SEER-Medicare.
about
Strategies for prevention of ultrasound-guided prostate biopsy infectionsInfection-Related Hospital Admissions After Prostate Biopsy in United States Men.Epigenetic Signature: A New Player as Predictor of Clinically Significant Prostate Cancer (PCa) in Patients on Active Surveillance (AS)Impact of a protein-based assay that predicts prostate cancer aggressiveness on urologists' recommendations for active treatment or active surveillance: a randomized clinical utility trial.Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up.Rectal Culture-Guided Targeted Antimicrobial Prophylaxis Reduces the Incidence of Post-Operative Infectious Complications in Men at High Risk for Infections Submitted to Transrectal Ultrasound Prostate Biopsy - Results of a Cross-Sectional Study.The PROFILE Feasibility Study: Targeted Screening of Men With a Family History of Prostate CancerRisk of hospitalization and death following prostate biopsy in Scotland.The Prostate Health Index: a new test for the detection of prostate cancer.Prevention and treatment of biopsy-related complications.Reducing infection rates after prostate biopsy.Active surveillance for clinically localized prostate cancer--a systematic review.Optimization of prostate biopsy: review of technique and complications.Atypical small acinar proliferation (ASAP): Is a repeat biopsy necessary ASAP? A multi-institutional review.Additional benefit of using a risk-based selection for prostate biopsy: an analysis of biopsy complications in the Rotterdam section of the European Randomized Study of Screening for Prostate Cancer.Reducing Infectious Complications Following Transrectal Ultrasound-guided Prostate Biopsy: A Systematic Review.Prevention of infectious complications after prostate biopsy procedure.Diffusion weighted imaging of the prostate-principles, application, and advances.Estimating the risks and benefits of active surveillance protocols for prostate cancer: a microsimulation study.Complications after prostate biopsies in men on active surveillance and its effects on receiving further biopsies in the Prostate cancer Research International: Active Surveillance (PRIAS) study.Prostate biopsy: results and advantages of the transperineal approach--twenty-year experience of a single center.Formalin disinfection of prostate biopsy needles may reduce post-biopsy infectious complications.A urine-based methylation signature for risk stratification within low-risk prostate cancer.[-2]proPSA is an early marker for prostate cancer aggressiveness.Atypical Small Acinar Proliferation and High Grade Prostatic Intraepithelial Neoplasia: Should We Be Concerned? An Observational Cohort Study with a Minimum Follow-Up of 3 Years.Atypical small acinar proliferation at index prostate biopsy: rethinking the re-biopsy paradigm.Biopsy Strategies in the Analysis of Urologic Neoplasia
P2860
Q26741156-F992BABD-538E-4A96-A057-5678EA1C4137Q33629055-132EBF55-03DF-4D24-BD85-2837994A0F47Q33838513-6C3C4C15-55E3-4C54-AA29-20D563B9B9F0Q33868433-02799A16-420E-4E00-998B-84DF257B70AFQ34041688-40047E1D-7B8B-4430-8129-272A2149FF5AQ36259927-FB7DD773-B0FA-4AE5-B15F-E54B924B06DEQ37017011-3F4FA5FA-89AE-4542-A00A-6771DE487C7EQ37579726-7806D671-F9BF-4961-A329-69A2EA3E6FF4Q37619016-BD95FF51-4513-4BFA-83FE-3372735ECE77Q38175326-82C274FB-704F-467F-8AC2-2742D709F195Q38178006-5AC92D90-E6E5-4F2F-99B8-23B4430FA2DDQ38194533-13255B5F-84EB-4270-9876-E4A77C08CC52Q38203986-27438C77-5AC0-47BF-8A07-42A98A5BF393Q38726541-A147B2A7-EBC1-4F0D-AA4E-3B5AA0C9F311Q38789338-AA44EAE1-2B2F-4003-8C27-12FEBB5B7E1CQ38948160-74AD566A-952C-4450-B789-61C00FBB3C8CQ39337754-B00178F2-0F86-4DEC-9046-B815ED15D82DQ39446440-1678E157-1D07-4B11-B259-6A6ECC76ACD7Q39738179-E0A1F119-3AC6-46D3-9961-33EA84B5A003Q40109539-C889AC7D-5397-43C8-BD13-034307225885Q40116168-F74E2BC4-4C97-4F58-A467-AE7349091CBCQ40360351-FDF8FA18-4129-401D-B04A-DE0ACADAB739Q42121326-AEAAB8FB-4800-4715-B0F8-6B8189E658BAQ44417584-A30196A2-56E0-4AE3-B0B6-6128656D1365Q47122685-7A1E4DB2-A498-4EAD-B2CA-5BDBA5064983Q48139219-1AAA3132-9FC0-46D8-A980-F067321E064CQ57766033-A4BB87CD-FF41-4EC8-8DD1-97FE080524F2
P2860
Is repeat prostate biopsy associated with a greater risk of hospitalization? Data from SEER-Medicare.
description
2012 nî lūn-bûn
@nan
2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
Is repeat prostate biopsy asso ...... tion? Data from SEER-Medicare.
@ast
Is repeat prostate biopsy asso ...... tion? Data from SEER-Medicare.
@en
type
label
Is repeat prostate biopsy asso ...... tion? Data from SEER-Medicare.
@ast
Is repeat prostate biopsy asso ...... tion? Data from SEER-Medicare.
@en
prefLabel
Is repeat prostate biopsy asso ...... tion? Data from SEER-Medicare.
@ast
Is repeat prostate biopsy asso ...... tion? Data from SEER-Medicare.
@en
P2093
P2860
P921
P1476
Is repeat prostate biopsy asso ...... tion? Data from SEER-Medicare.
@en
P2093
H Ballentine Carter
Sonja I Berndt
Winnie Ricker
P2860
P304
P356
10.1016/J.JURO.2012.10.005
P407
P577
2012-10-09T00:00:00Z